50742-37-5

Basic information

• Product Name: 3-PHENOXY-BENZYLAMINE
• Synonyms: TIMTEC-BB SBB010981;IFLAB-BB F1983-0042;AKOS BC-3045;(3-PHENOXYPHENYL)METHYLAMINE;3-PHENOXY-BENZYLAMINE
• CAS NO: 50742-37-5
• Molecular Formula: C₁₃H₁₃NO
• Molecular Weight: 199.25
• Mol File: 50742-37-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 322.6±25.0 °C(Predicted)
• Appearance: /
• Density: 1.106±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 8.91±0.10(Predicted)
• CAS DataBase Reference: 3-PHENOXY-BENZYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-PHENOXY-BENZYLAMINE(50742-37-5)
• EPA Substance Registry System: 3-PHENOXY-BENZYLAMINE(50742-37-5)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 50742-37-5(Hazardous Substances Data)

Usage

General Description

3-Phenoxy-benzylamine is a chemical compound with the molecular formula C14H15NO. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 3-PHENOXY-BENZYLAMINE is a colorless to light yellow liquid with a faint odor, and it is insoluble in water but soluble in organic solvents. It is classified as a primary aromatic amine, and it is important to handle it with caution and use appropriate safety measures due to its potential hazards. 3-Phenoxy-benzylamine is commonly used in the manufacturing of various products and plays a crucial role as a building block in organic synthesis processes.

Upstream product

• 13826-35-2 3-Phenoxybenzyl alcohol 
• 88467-12-3 3-phenoxybenzyl methanesulfonate 
• 39515-51-0 3-Phenoxybenzaldehyde 

Downstream Products

• 864176-55-6 {4-[3-(3-phenoxy-benzyl)-ureidomethyl]-benzyl}-carbamic acid tert-butyl ester 
• 74240-76-9 N-cyclohexylidene(3-phenoxybenzylamine) 
• 74672-19-8 N-isobutylidene-(3-phenoxybenzylamine) 
• 74240-72-5 N-3-pentylidene-(3-phenoxybenzylamine) 
• 1376394-75-0 C₁₆H₁₉NO₄S 
• 1089332-95-5 C₁₄H₁₅NO₃S 
• 1376376-07-6 C₂₀H₁₉NO₃S 
• 1347757-08-7 (S)-N-(3-phenoxybenzyl)-1-(2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)-3-piperidinecarboxamide 
• 1283596-10-0 C₂₄H₂₆N₂O₂ 
• 179056-63-4 C₂₀H₁₉NO 
• 849810-85-1 Quinazoline-6-carboxylic acid 3-phenoxybenzylamide 
• 849806-49-1 (3-Phenoxy-benzyl)-carbamic acid phenyl ester 
• 849810-93-1 benzothiazole-6-carboxylic acid 3-phenoxybenzylamide 
• 104290-68-8 3,3-Dimethyl-2-phenyl-cycloprop-1-enecarboxylic acid 3-phenoxy-benzyl ester 

Relevant articles and documents

AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER ACTIVITY

Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.

NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND

The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].

Therapeutic substituted indole compounds and compositions thereof

The present invention is concerned with compounds of formula (I) STR1 wherein R, R1 and R2 are independently selected from hydrogen and C1-4 alkyl; R3 and R4 are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R3 benzyl or substituted benzyl when R4 =H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) STR2 wherein Y is selected from oxygen, methylene and >N--R5, where R5 is hydrogen, C1-4 alkyl, or benzyl, Z and Z' are independently selected from >C=O, >C=S and methylene, and the chiral center * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.